MedPath
HSA Product

RESINCOLESTIRAMINA POWDER

Product approved by Health Sciences Authority (SG)

Basic Information

RESINCOLESTIRAMINA POWDER

POWDER

Regulatory Information

SIN06583P

September 27, 1991

Prescription Only

Therapeutic

ORAL

August 10, 2023

June 4, 2025

XC10AC01

Company Information

ZYFAS PHARMA PTE LTD

ZYFAS PHARMA PTE LTD

Active Ingredients

Detailed Information

Contraindications

**CONTRAINDICATIONS** It is contraindicated in patients with complete biliary obstruction and in those individuals who have shown hypersensitivity to any of its components.

Indication Information

**INDICATIONS** RESINCOLESTIRAMINA is indicated as adjunctive therapy in hypercholesterolaemia and as an adjunct for the relief of intractable diarrhoea and for the relief of pruritus secondary to biliary stasis.

© Copyright 2025. All Rights Reserved by MedPath